Research Topics
| Jeffrey A BogartSummaryAffiliation: SUNY Upstate Medical University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Fractionated radiotherapy for high-risk patients with early-stage non-small cell lung cancerJeffrey A Bogart
Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, New York, USA
Semin Thorac Cardiovasc Surg 22:44-52. 2010..This review will focus on the potential current role of fractionated radiotherapy for high-risk patients with particular consideration of altered fractionation schemes and recent advances in treatment related technology...
Stereotactic body radiotherapy for poor-risk lung cancer: "more cyber, less knife?"Jeffrey A Bogart
Department of Radiation Oncology, Upstate Medical University, Syracuse, NY 13210, USA
Cancer J 13:75-7. 2007- Radiation oncology research in the cancer and leukemia group BJeffrey A Bogart
Upstate Medical University, Syracuse, New York, USA
Clin Cancer Res 12:3628s-34s. 2006.... - Dose-intensive thoracic radiation therapy for patients at high risk with early-stage non-small-cell lung cancerJeffrey A Bogart
Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
Clin Lung Cancer 6:350-4. 2005..Moderately accelerated single daily fractionated RT is feasible for high-risk patients with early-stage NSCLC and merits further investigation... - Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235Jeffrey A Bogart
SUNY Upstate Medical University, Radiation Oncology Department, 750 E Adams Street, Syracuse, NY 13210, United States
Lung Cancer 62:92-8. 2008..We examined the association between TRT duration and outcomes on a prospective phase III study... - 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808Jeffrey A Bogart
Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
Int J Radiat Oncol Biol Phys 59:460-8. 2004..To prospectively evaluate the feasibility of delivering 70 Gy once-daily thoracic radiotherapy (TRT), concurrent with chemotherapy, in the treatment of limited-stage small-cell lung cancer (L-SCLC)... - Rationale for phase III trials of thoracic radiation therapy doses in limited-stage small-cell lung cancerJeffrey A Bogart
Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
Clin Lung Cancer 9:202-5. 2008..The rationale for these trials is described herein... 
Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904Jeffrey A Bogart
Department of Radiation Oncology, State University of New York Upstate Medical University, 750 E Adams St, Syracuse NY 13210, USA
J Clin Oncol 28:202-6. 2010..The optimal treatment for medically inoperable stage I non-small-cell lung cancer (NSCLC) has not been defined...- Early stage medically inoperable non-small cell lung cancerJeffrey A Bogart
Department of Radiation Oncology, Upstate Medical University, 750 E Adams Street, Syracuse, NY 13210, USA
Curr Treat Options Oncol 4:81-8. 2003..Trials involving systemic therapy for patients with medically inoperable NSCLC should be developed... - Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapyJeffrey A Bogart
Department of Radiation Oncology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
Clin Cancer Res 11:5004s-5010s. 2005..We will review the data on PORT and address critical issues in the design of trials to assess the role of modern radiotherapy in the integrated approach to management of early-stage NSCLC... - Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia GrouJoseph K Salama
Department of Radiation Oncology, Box 3085, Duke University Medical Center, Durham, NC 27710, USA
Int J Radiat Oncol Biol Phys 81:e269-74. 2011..We conducted a secondary analysis of all patients to determine predictors of treatment-related pulmonary toxicity... - Definitive treatment of poor-risk patients with stage I lung cancer: a single institution experienceMichael Hsie
SUNY Upstate Medical University, Department of Radiation Oncology, Syracuse, New York, USA
J Thorac Oncol 4:69-73. 2009..The appropriate management for this population has not been defined... - Radiotherapy for the clinically negative neck in supraglottic laryngeal cancerTracy E Alpert
Department of Radiation Oncology, Upstate Medical University, Syracuse, New York 13210, USA
Cancer J 10:335-8. 2004..Prospective trials are necessary to further define the role of radiotherapy in this patient population... - Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trialsJohn W Powell
Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
Lancet Oncol 10:885-94. 2009..Ongoing challenges are presented and prospective data are emphasised... - A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancerJeffrey A Bogart
Department of Radiation Oncology, Upstate Medical University, Syracuse, NY, USA
Clin Lung Cancer 7:285-7. 2006 - Gamma knife surgery for trigeminal neuralgia: improved initial response with two isocenters and increasing doseTracy E Alpert
Department of Radiation Oncology and Neurosurgery, Upstate Medical University, Syracuse, New York 13210, USA
J Neurosurg 102:185-8. 2005..001). There were no severe complications. Five patients developed mild facial numbness. CONCLUSIONS: Gamma knife surgery is an effective therapy for TN. Initial response rates appear to correlate with the number of shots and dose... - Radiotherapy for moderate-to-severe Graves' ophthalmopathy: improved outcomes with early treatmentTracy E Alpert
Department of Radiation Oncology, Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
Cancer J 9:472-5. 2003..The purpose of this review is to quantify the response to radiotherapy delivered early in the active inflammatory phase of moderate-to-severe Graves' ophthalmopathy... - Successful treatment of spindle cell sarcoma of the sella turcica. Case reportTracy E Alpert
Department of Radiation Oncology, State University of New York Upstate Medical University, Syracuse, New York 13210, USA
J Neurosurg 97:438-40. 2002..After 24 months of follow up, the patient continues to show no evidence of disease... - Radiation therapy-related toxicity (including pneumonitis and fibrosis)Rahul R Chopra
Department of Radiation Oncology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
Emerg Med Clin North Am 27:293-310. 2009..This article is designed to acquaint emergency medicine physicians with common, expected, and potential acute and late complications of RT... - Radiation therapy-related toxicity (including pneumonitis and fibrosis)Rahul R Chopra
Department of Radiation Oncology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
Hematol Oncol Clin North Am 24:625-42. 2010..This article is designed to acquaint the reader with common, expected, and potential acute and late complications of RT... - Autopsy evaluation of a prostate cancer case treated with brachytherapyAnna Shapiro
Department of Radiation Oncology, Upstate Medical University, Syracuse, NY 13210, USA
Anticancer Res 28:3909-12. 2008..It is crucial that this uncertainty is kept in mind in making further management decisions in patients who have undergone radiation therapy and follow-up biopsy of the prostate gland... - Hypofractionated radiotherapy for advanced non-small-cell lung cancer: is the LINAC half full?Jeffrey A Bogart
J Clin Oncol 22:765-8. 2004 - Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105Mark A Socinski
Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, NC 27599, USA
J Clin Oncol 26:2457-63. 2008..To evaluate 74 Gy thoracic radiation therapy (TRT) with induction and concurrent chemotherapy in stage IIIA/B non-small-cell lung cancer (NSCLC)... - Limited-stage small-cell lung cancer: the current status of combined-modality therapyMark A Socinski
Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
J Clin Oncol 25:4137-45. 2007..LS-SCLC has been a model cancer in terms of the potential benefit of combined chemoradiotherapy strategies in improving patient outcomes... - Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002Antonius A Miller
Comprehensive Cancer Center, Wake Forest University, Winston Salem, North Carolina, USA
J Thorac Oncol 2:645-51. 2007.... - Definitive radiotherapy for stage I non-small cell lung cancer: ain't nothing like the real thing?Jeffrey A Bogart
J Thorac Oncol 1:763-5. 2006 - Early stage lung cancer--new approaches to evaluation and treatment: conference summary statementThomas J Lynch
Division of Hematology/Oncology and Dana-Farber/Partners Cancer Care, Massachusetts General Hospital, 100 Blossom Street, Boston, MA 02114, USA
Clin Cancer Res 11:4981s-4983s. 2005 - Hypofractionated irradiation for non-small cell lung cancerRaymond P Abratt
Department of Radiation Medicine, Division of Radiation Oncology, Groote Schuur Hospital and University of Cape Town, Observatory 7925, Cape Town, South Africa
Lung Cancer 36:225-33. 2002..However, more advanced tumours may be treated with hypofractionation to lower total doses to achieve palliation and a modest degree of survival benefit...